Literature DB >> 19394683

Gain of 3q26: a genetic marker in low-grade squamous intraepithelial lesions (LSIL) of the uterine cervix.

Antti Seppo1, G Reza Jalali, Robert Babkowski, Hera Symiakaki, Alexandros Rodolakis, Triantafyllos Tafas, Petros Tsipouras, Michael W Kilpatrick.   

Abstract

OBJECTIVE: Physicians have few resources for determining which LSIL will progress to HSIL or regress. Recently the chromosome 3q26 region was found to be amplified in patients with cervical cancer. The frequency of this 3q gain increased with severity of dysplasia. The primary objective of this study was to evaluate an automated FISH assay for detection of 3q gain in liquid cytology samples as a potential tool for risk stratification and triaging.
METHODS: Slides prepared from 257 liquid cytology specimens (97 Negative, 135 LSIL 25 HSIL) were hybridized with a single-copy probe for the chromosome 3q26 region and a probe for the centromeric alpha-repeat sequence of chromosome 7, using standard FISH methods. Using automated analysis, the total number of nuclei and the number of nuclei with >2 signals for 3q26 were determined, using a 20x objective. The nuclei were rank ordered based on number of 3q26 FISH signals. The 800 nuclei with the highest number of signals were scored using both FISH probes and nuclei with increased numbers of 3q signals were enumerated. RESULTS AND
CONCLUSIONS: Analysis of 257 specimens demonstrated that a fully automated FISH scoring system can detect 3q gain in liquid cytology samples. A fully automated method for determination of 3q gain in liquid cytology may be the assay necessary to implement routine testing. Additional studies to validate the utility of this technology are needed.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19394683     DOI: 10.1016/j.ygyno.2009.03.031

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  7 in total

Review 1.  Human Papillomavirus Laboratory Testing: the Changing Paradigm.

Authors:  Eileen M Burd
Journal:  Clin Microbiol Rev       Date:  2016-04       Impact factor: 26.132

2.  Analysis of genetic copy number changes in cervical disease progression.

Authors:  Frank A Policht; Minghao Song; Svetlana Sitailo; Anna O'Hare; Raheela Ashfaq; Carolyn Y Muller; Larry E Morrison; Walter King; Irina A Sokolova
Journal:  BMC Cancer       Date:  2010-08-16       Impact factor: 4.430

3.  Chromosomal gains measured in cytology samples from women with abnormal cervical cancer screening results.

Authors:  Patricia Luhn; Jane Houldsworth; Lynnette Cahill; Mark Schiffman; Philip E Castle; Rosemary E Zuna; S Terence Dunn; Michael A Gold; Joan Walker; Nicolas Wentzensen
Journal:  Gynecol Oncol       Date:  2013-06-13       Impact factor: 5.482

4.  Biomarkers of cervical dysplasia and carcinoma.

Authors:  Sonya J Hwang; Kenneth R Shroyer
Journal:  J Oncol       Date:  2011-10-29       Impact factor: 4.375

5.  3q26 amplification is an effective negative triage test for LSIL: a historical prospective study.

Authors:  Erica R Heitmann; Kamani M Lankachandra; Jeff Wall; George D Harris; Hollie J McKinney; G Reza Jalali; Yogita Verma; Eric Kershnar; Michael W Kilpatrick; Petros Tsipouras; Diane M Harper
Journal:  PLoS One       Date:  2012-07-06       Impact factor: 3.240

6.  TP53 and PIK3CA gene mutations in adenocarcinoma, squamous cell carcinoma and high-grade intraepithelial neoplasia of the cervix.

Authors:  Maria Lina Tornesello; Clorinda Annunziata; Luigi Buonaguro; Simona Losito; Stefano Greggi; Franco M Buonaguro
Journal:  J Transl Med       Date:  2014-09-16       Impact factor: 5.531

Review 7.  Gain of Chromosomal Region 3q26 as a Prognostic Biomarker for High-Grade Cervical Intraepithelial Neoplasia: Literature Overview and Pilot Study.

Authors:  Margot M Koeneman; Irene T Ovestad; Emiel A M Janssen; Monique Ummelen; Roy F P M Kruitwagen; Anton H Hopman; Arnold J Kruse
Journal:  Pathol Oncol Res       Date:  2018-10-25       Impact factor: 3.201

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.